Dear colleagues,
In recent years, the global field of cerebrovascular disease research has experienced vigorous development, with a significant improvement in the quality of clinical research and a continuous emergence of innovative achievements. These advancements have provided new perspectives and directions for addressing a series of clinical challenges. Particularly noteworthy is the explosive growth of research achievements by Chinese scholars on the international stage over the past two years. Numerous top domestic researchers have showcased the dynamic vitality and outstanding accomplishments of China's cerebrovascular disease research through high-quality innovative studies. The academic strength of China has deeply integrated into the international cerebrovascular disease research community, becoming a crucial engine driving the advancement of this field, fully demonstrating the remarkable progress China has made in this area. Looking ahead to 2025, this development trend will become even more pronounced, and China's research contributions will gain broader recognition and attention worldwide.
In the new era of deep integration between technological innovation and medical development, we remain committed to exploring collaborative innovation pathways between cutting-edge technology and clinical medicine. We continuously inject new momentum into the improvement of medical quality and disciplinary development in the field of cerebrovascular disease in China, propelling the field towards a new stage of high-quality development. In this context, we sincerely invite you to attend the 11th Annual Conference of the Chinese Stroke Association & TianTan International Stroke Conference 2025(CSA&TISC 2025), which will be held from July 4th to 6th, 2025, at the China National Convention Center Phase II in Beijing. This conference will deeply focus on the latest research advancements in the field of cerebrovascular disease, featuring meticulously organized forums on topics such as intravenous thrombolysis, mechanical thrombectomy, secondary prevention, and rehabilitation therapy. We will gather top experts and scholars from both domestic and international arenas to share the latest research findings and clinical practical experiences through keynote speeches and academic discussions, jointly exploring the frontier technologies and clinical applications in stroke prevention and treatment.
We are confident that this annual conference will become a landmark academic event in the field of stroke, not only providing a high-level platform for academic exchange and fostering in-depth collaboration and synergistic innovation among experts worldwide but also vigorously promoting the leapfrog development in stroke prevention and treatment. We eagerly anticipate your participation to collectively witness the latest breakthroughs and achievements in stroke research and treatment.
We look forward to welcoming you in Beijing for this grand academic gathering!
Chinese Stroke Association
The Organizing Committee of the 11th Annual Conference
of CSA&TISC 2025
